Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

0.2990
+0.01585.58%
Post-market: 0.30000.0010+0.33%18:18 EDT
Volume:225.23K
Turnover:64.47K
Market Cap:13.78M
PE:-0.21
High:0.2990
Open:0.2832
Low:0.2775
Close:0.2832
Loading ...
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Oct 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report